Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 2 |
2013 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Contribution of renal and non-renal clearance on increased total clearance of adalimumab in glomerular disease.
J Clin Pharmacol. 2013 Sep;53(9):919-24. doi: 10.1002/jcph.121. Epub 2013 Jun 29.
J Clin Pharmacol. 2013.
PMID: 23813330
Free article.
Clinical Trial.
Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group.
Peyser A, Machardy N, Tarapore F, Machardy J, Powell L, Gipson DS, Savin V, Pan C, Kump T, Vento S, Trachtman H.
Peyser A, et al.
BMC Nephrol. 2010 Jan 29;11:2. doi: 10.1186/1471-2369-11-2.
BMC Nephrol. 2010.
PMID: 20113498
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group.
Joy MS, Gipson DS, Powell L, MacHardy J, Jennette JC, Vento S, Pan C, Savin V, Eddy A, Fogo AB, Kopp JB, Cattran D, Trachtman H.
Joy MS, et al.
Am J Kidney Dis. 2010 Jan;55(1):50-60. doi: 10.1053/j.ajkd.2009.08.019. Epub 2009 Nov 22.
Am J Kidney Dis. 2010.
PMID: 19932542
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite